Technology | August 23, 2013

Active Breathing Coordinator receives CE marking and 510(k) clearance


August 23, 2013 — Users of linear accelerator, Versa HD, can now bring target immobilization to new levels through automated gating with Active Breathing Coordinator. For anatomies affected by respiratory motion, such as lung, liver and breast, Active Breathing Coordinator provides non-invasive, internal immobilization of the target, triggering radiation delivery when anatomy is immobilized.

Automated gating with Active Breathing Coordinator recently received CE marking from the European Union and 510(k) clearance from the U.S. Food and Drug Administration (FDA), and in combination with Elekta's Response gating interface, provides additional benefits to both the Versa HD clinically tailored solutions for treating breast and lung cancers.

Active Breathing Coordinator helps patients pause their breathing at a precisely indicated tidal volume – a deep-inspiration breath-hold – which increases the distance between the tumor and critical structures, resulting in the ability to reduce doses to the critical structures.

By consistently immobilizing the target in an identifiable, repeatable and stationary position, clinicians are better able to reduce tumor margins and implement dose escalation and hypofractionation strategies, such as stereotactic body radiation therapy (SBRT). Automated beam delivery increases clinical confidence and efficiency, in addition to reducing treatment times over manual techniques.

"We use Active Breathing Coordinator for lung and liver cancer treatments, and in combination with high dose rate mode that is now available with Versa HD, we are able to deliver breath-hold gated SBRT treatments with IGRT [image-guided radiation therapy] in a standard treatment time slot of 15 minutes," says Frank Lohr, vice chairman, University Medical Centre Mannheim. 

For more information: www.elekta.com


Related Content

News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
Subscribe Now